Lilly’s oral drug helps reduce blood sugar levels in late-stage trials
(Reuters) -Eli Lilly said on Wednesday its experimental pill, orforglipron, helped reduce blood sugar levels in two late-stage trials. The oral drug is designed to mimic the appetite-suppressing GLP-1 hormone…